SAN DIEGO, March 28, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming conferences:
Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days
Tuesday, April 4, 2023, at 3:55 p.m. ET
BofA Securities 2023 Health Care Conference
Wednesday, May 10, 2023, at 3:40 p.m. PT
Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
| Media: Nivi Nehra Vice President, Corporate Communications 888-969-7879 mediarelations@travere.com | Investors: Naomi Eichenbaum Vice President, Investor Relations 888-969-7879 IR@travere.com |
